Nectero Medical
Latest round
- Series D
Last raised
- Apr 2024
Total raised
- $52M
Investors
- 6
About Nectero Medical
Founded in 2017 and based in Arizona, US, Nectero Medical, Inc. operates as a biotechnology company developing a minimally invasive treatment for small- to mid-sized AAAs. In April 2024, Nectero Medical Inc.81 million post-money. Nectero Medical is a clinical-stage biotech platform that develops novel therapies for patients with infrarenal abdominal aortic aneurysms (AAAs).5–5 cm).S. Food and Drug Administration.
Who invested in Nectero Medical
6 investors across 2 rounds
See all investors in Nectero Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nectero Medical
Who invested in Nectero Medical?
Nectero Medical has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nectero Medical raised?
Nectero Medical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nectero Medical last raise money?
Nectero Medical's most recent round on record is a Series D, in Apr 2024.
What does Nectero Medical do?
Founded in 2017 and based in Arizona, US, Nectero Medical, Inc.
Where is Nectero Medical headquartered?
Nectero Medical is headquartered in Tempe, US.
Which VCs invest in companies like Nectero Medical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nectero Medical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Nectero Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.